Disclosed herein are methods of treating multiple myeloma in a human patient in need thereof, comprising administering to the human patient a population of allogeneic cells comprising WT1-specific allogeneic T cells. Also disclosed herein are methods of treating plasma cell leukemia in a human patient in need thereof, comprising administering to the human patient a population of allogeneic cells comprising WT1-specific allogeneic T cells.本文揭示治療有需要之人類患者之多發性骨髓瘤之方法，其包含向該人類患者投與包含WT1特異性同種異體T細胞之同種異體細胞之群體。本文亦揭示治療有需要之人類患者之漿細胞白血病之方法，其包含向該人類患者投與包含WT1特異性同種異體T細胞之同種異體細胞之群體。
